| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.42 | 0.004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |